Business
Novo Nordisk Raises Outlook as Wegovy Pill Sales Hit $810 Million
Novo Nordisk raised its 2026 outlook for a third time after third-quarter sales of its Wegovy weight-loss pill beat forecasts,…
Novo Nordisk raised its 2026 outlook for a third time after third-quarter sales of its Wegovy weight-loss pill beat forecasts,…